0001104659-24-069618.txt : 20240607 0001104659-24-069618.hdr.sgml : 20240607 20240607160227 ACCESSION NUMBER: 0001104659-24-069618 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nelson Steven Charles CENTRAL INDEX KEY: 0002025906 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37704 FILM NUMBER: 241029189 MAIL ADDRESS: STREET 1: 322 W 57TH ST STREET 2: #33B CITY: NEW YORK STATE: NY ZIP: 10020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DarioHealth Corp. CENTRAL INDEX KEY: 0001533998 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 452973162 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 322 W 57TH ST. #33B CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 972-4-770-6377 MAIL ADDRESS: STREET 1: 322 W 57TH ST. #33B CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: LabStyle Innovations Corp. DATE OF NAME CHANGE: 20111101 4 1 tm2416654-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-06-05 0 0001533998 DarioHealth Corp. DRIO 0002025906 Nelson Steven Charles 322 W 57TH ST, #33B NEW YORK NY 10011 0 1 0 0 Chief Commercial Officer 0 Stock Option (right to buy) 1.35 2024-06-05 4 A 0 500000 0 A 2034-06-05 Common Stock 500000 500000 D Stock Option (right to buy) 1.35 2024-06-05 4 A 0 400000 0 A 2034-06-05 Common Stock 400000 400000 D Stock Option (right to buy) 1.35 2024-06-05 4 A 0 1200000 0 A 2034-06-05 Common Stock 1350000 1350000 D The options vest as follows: 500,00 shares vest over three years in three equal yearly amounts, subject to the Reporting Person's continued services to the Issuer on the applicable vesting date. The options vest immediately upon achieving certain milestones relating to the achievement of revenues (on a U.S. generally accepted account principles basis) for the year ending December 31, 2024. The options vest as follows: 400,000 shares begin to vest over three years in 12 equal quarterly amounts upon achieving certain milestones relating to the achievement of revenues (on a U.S. generally accepted account principles basis) for each of the years ending December 31, 2025, December 31, 2026 and December 31, 2027. /s/ Steven Nelson 2024-06-07